TABLE 3.
Sample | PT |
FHA |
PRN |
FIM |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | SIa | Pb | % CMI+c | n | SI | P | % CMI+ | n | SI | P | % CMI+ | n | SI | P | % CMI+ | |
Pre-primary series | 34 | 0.9, 1.0, 1.2 | 0 | 28 | 0.1, 0.2, 0.3 | 0 | 27 | 1.0, 1.5, 2.5 | 15 | 25 | 0.6, 0.8, 1.0 | 0 | ||||
Post-primary series | 33 | 2.5, 3.9, 5.8 | <0.001 | 67 | 29 | 0.4, 0.7, 1.5 | 0.008 | 7 | 29 | 1.9, 3.0, 5.5 | 0.002 | 52 | 24 | 1.1, 1.3, 1.6 | <0.001 | 12 |
Prebooster | 43 | 1.2, 1.7, 3.2 | 0.032 | 37 | 34 | 0.3, 0.6, 1.4 | 0.984 | 9 | 31 | 1.4, 2.0, 2.8 | 0.058 | 19 | 27 | 0.8, 1.1, 1.7 | 1 | 0 |
Postbooster | 37 | 1.3, 3.3, 5.1 | 54 | 29 | 0.3, 0.9, 2.1 | 14 | 21 | 1.2, 1.7, 2.5 | 24 | 18 | 0.7, 1.1, 1.5 | 0 |
SI is presented as median with interquartile range (lower quartile, median, upper quartile).
The magnitudes of T cell proliferative responses were compared between the pre- and post-primary series time points and between the post-primary series and prebooster time points by using the Wilcoxon signed-rank test. A P value of ≤0.05 is considered statistically significant.
Percentage of subjects with a positive cell-mediated immune response (i.e., SI ≥ 3).